• 1. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 2. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 3. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 4. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 5. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409

Professional Introduction to 3-(1-Adamantyl)-4-Methoxyphenylboronic Acid (CAS No. 459423-32-6)

3-(1-Adamantyl)-4-Methoxyphenylboronic Acid, with the chemical identifier CAS No. 459423-32-6, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and materials science. This boronic acid derivative is characterized by its unique structural features, which include a bulky 1-adamantyl group and a methoxy-substituted phenyl ring. These structural elements contribute to its distinct chemical properties, making it a valuable intermediate in various synthetic applications.

The compound's molecular structure, featuring a boronic acid functional group, positions it as a key reagent in Suzuki-Miyaura cross-coupling reactions. These reactions are fundamental in the synthesis of complex organic molecules, particularly in the development of novel pharmaceuticals and advanced materials. The presence of the 1-adamantyl moiety enhances the steric stability of the boronic acid, improving its reactivity and selectivity in such transformations.

In recent years, there has been growing interest in boronic acid derivatives due to their role as pharmacophores and intermediates in drug discovery. The combination of the rigid adamantane core and the electron-donating methoxy group in 3-(1-Adamantyl)-4-Methoxyphenylboronic Acid makes it an attractive candidate for further exploration in medicinal chemistry. Studies have demonstrated its utility in the synthesis of biaryl compounds, which are prevalent in many bioactive molecules.

One of the most compelling aspects of this compound is its potential application in the development of targeted therapeutics. Boronic acids are known for their ability to form reversible covalent bonds with biological targets, making them effective tools for drug design. The unique properties of 3-(1-Adamantyl)-4-Methoxyphenylboronic Acid suggest that it could be used to create novel inhibitors or probes for various biological pathways.

The synthesis of this compound involves multi-step organic reactions, typically starting from commercially available precursors such as 1-adamantanol and 4-methoxyphenol. Advanced synthetic techniques, including palladium-catalyzed coupling reactions and protective group strategies, are employed to achieve high yields and purity. The complexity of its synthesis underscores its value as a specialized chemical reagent.

Recent research has highlighted the role of boronic acid derivatives in materials science, particularly in the development of organic electronic devices. The electron-deficient nature of the phenyl ring and the electrophilic boron center make this compound a promising candidate for use in conductive polymers and other advanced materials. Its ability to form stable complexes with metals also opens up possibilities for applications in catalysis and coordination chemistry.

The pharmaceutical industry has been particularly interested in exploring the therapeutic potential of boronic acid derivatives due to their unique interaction with biological systems. For instance, studies have shown that certain boronic acids can inhibit enzymes by binding to their active sites through reversible covalent interactions. This mechanism has been exploited in the development of drugs such as erlotinib, which is used to treat certain types of cancer.

The< strong>1-adamantyl group in 3-(1-Adamantyl)-4-Methoxyphenylboronic Acid adds an additional layer of complexity to its biological activity. Adamantane derivatives are known for their high metabolic stability and low toxicity, making them suitable candidates for drug development. The combination of these properties with the reactivity provided by the boronic acid functional group suggests that this compound could be a valuable tool in creating next-generation therapeutics.

In conclusion, 3-(1-Adamantyl)-4-Methoxyphenylboronic Acid (CAS No. 459423-32-6) is a multifaceted compound with significant potential applications across multiple scientific disciplines. Its unique structural features make it an excellent candidate for use as an intermediate in pharmaceutical synthesis, a reagent in materials science, and a probe for biological research. As our understanding of its properties continues to grow, it is likely that new applications will emerge, further solidifying its importance in modern chemistry.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)